C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.[C:23]([O:26][C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=1/[CH:33]=[CH:34]\[C:35]([OH:37])=O)(=[O:25])[CH3:24].ClC(Cl)C.[NH2:42][C@H:43]1[CH2:48][CH2:47][CH2:46][CH2:45][C@H:44]1[NH:49][C:50]1[N:55]=[C:54]([NH:56][C:57]2[CH:62]=[CH:61][CH:60]=[C:59]([CH3:63])[CH:58]=2)[C:53]([C:64]([NH2:66])=[O:65])=[CH:52][N:51]=1>O.CN(C=O)C>[C:23]([O:26][C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=1/[CH:33]=[CH:34]\[C:35](=[O:37])[NH:42][C@@H:43]1[CH2:48][CH2:47][CH2:46][CH2:45][C@@H:44]1[NH:49][C:50]1[N:55]=[C:54]([NH:56][C:57]2[CH:62]=[CH:61][CH:60]=[C:59]([CH3:63])[CH:58]=2)[C:53]([C:64](=[O:65])[NH2:66])=[CH:52][N:51]=1)(=[O:25])[CH3:24]A 135 mg portion of HOBt and 192 mg of WSC·HCl were added to a mixture of 195 mg of (Z)-3-[2-(acetoxy)phenyl]acrylic acid and 10 ml of dichloroethane, followed by stirring for 20 minutes under ice-cooling. Then, 2 ml of DMF solution containing 340 mg of 2-(cis-2-aminocyclohexylamino)-4-(3-methylanilino)pyrimidine-5-carboxamide was added, followed by stirring at room temperature for 2 hours. Water was added to the reaction mixture, followed by extraction with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under a reduced pressure. The resulting residue was purified by silica gel column chromatography (eluting solvent; chloroform:methanel) and then the thus obtained colorless solid was recrystallized from ethyl acetate, thereby obtaining 98 mg of 2-{(Z)-2-[(cis-2-{[5-carbamoyl-4-(3-methylanilino)pyrimidin-2-yl]amino}cyclohexyl)carbamoyl]vinyl}phenyl acetate (colorless crystals).
불러오는 중…